Explore how PPARγ, a nuclear receptor originally studied for metabolism, has emerged as a promising cancer therapy target through its dual role in tumor regulation.
Discover how cooperative cobinding in PPARγ nuclear receptor is transforming drug discovery for diabetes, fatty liver disease, and metabolic disorders.